Predictive Biosciences

About:

Predictive Biosciences is a molecular diagnostics company developing diagnostic products for informed cancer management.

Website: http://www.predictivebiosci.com

Top Investors: Chiratae Ventures, New Enterprise Associates, Kaiser Permanente Ventures, Flybridge, Highland Capital Partners

Description:

Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient. Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.